Global Medical REIT (NYSE:XRN) Given New $40.00 Price Target at BMO Capital Markets

Posted by George Bondi on Jul 13th, 2026

Global Medical REIT (NYSE:XRN – Get Free Report) had its price objective lifted by equities research analysts at BMO Capital Markets from $39.00 to $40.00 in a research note issued to investors on Monday,Benzinga reports. The firm currently has a “market perform” rating on the stock. BMO Capital Markets’ price objective indicates a potential upside of 10.19% from the company’s current price.

Several other analysts have also recently issued reports on XRN. Wall Street Zen cut Global Medical REIT from a “hold” rating to a “sell” rating in a research note on Saturday, May 9th. Citizens Jmp lifted their target price on Global Medical REIT from $40.00 to $42.00 and gave the stock a “market outperform” rating in a research report on Tuesday, May 26th. Compass Point reiterated a “neutral” rating and issued a $38.00 price target (down from $50.00) on shares of Global Medical REIT in a report on Thursday, May 7th. Weiss Ratings upgraded Global Medical REIT from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, July 6th. Finally, Raymond James Financial began coverage on shares of Global Medical REIT in a report on Wednesday, June 17th. They issued a “market perform” rating for the company. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat.com, Global Medical REIT presently has an average rating of “Moderate Buy” and an average price target of $40.25.

View Our Latest Report on Global Medical REIT

Global Medical REIT Price Performance

XRN opened at $36.30 on Monday. The company has a market capitalization of $480.28 million, a P/E ratio of -32.70 and a beta of 1.10. The company has a 50-day moving average of $35.98 and a 200-day moving average of $35.49. The company has a debt-to-equity ratio of 1.68, a quick ratio of 0.68 and a current ratio of 0.68. Global Medical REIT has a 1-year low of $29.05 and a 1-year high of $39.93.

Insider Buying and Selling

In related news, COO Danica Holley bought 1,490 shares of the stock in a transaction dated Tuesday, May 12th. The stock was bought at an average cost of $33.99 per share, with a total value of $50,645.10. Following the completion of the acquisition, the chief operating officer owned 1,590 shares of the company’s stock, valued at $54,044.10. This trade represents a 1,490.00% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, General Counsel Jamie Allen Barber bought 1,481 shares of the stock in a transaction dated Tuesday, May 12th. The shares were bought at an average cost of $33.50 per share, with a total value of $49,613.50. Following the completion of the acquisition, the general counsel directly owned 1,481 shares of the company’s stock, valued at approximately $49,613.50. The trade was a ∞ increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders acquired a total of 10,974 shares of company stock valued at $373,826 over the last 90 days. 8.90% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the stock. Invesco Ltd. increased its position in Global Medical REIT by 4.2% in the fourth quarter. Invesco Ltd. now owns 310,432 shares of the company’s stock worth $10,474,000 after buying an additional 12,471 shares during the period. Mackenzie Financial Corp bought a new stake in Global Medical REIT in the fourth quarter valued at $563,000. XTX Topco Ltd acquired a new position in shares of Global Medical REIT during the fourth quarter valued at $515,000. Tudor Investment Corp ET AL acquired a new position in shares of Global Medical REIT during the fourth quarter valued at $930,000. Finally, Clifford Capital Partners LLC grew its position in shares of Global Medical REIT by 31.3% during the fourth quarter. Clifford Capital Partners LLC now owns 14,694 shares of the company’s stock worth $496,000 after acquiring an additional 3,504 shares during the last quarter. 57.52% of the stock is currently owned by institutional investors.

About Global Medical REIT

(Get Free Report)

Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.